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Outcome of children with sickle cell disease admitted to
intensive care – a single institution experience
Sickle cell disease (SCD) is one of the commonest severe
genetic disorders in England, affecting over 1 in 2000 live
births (Streetly et al, 2009). Children with SCD can become
critically ill requiring referral to intensive care units. The most
common causes of death in children with SCD are acute, and
include infection, acute chest syndrome (ACS) and stroke
(Leikin et al, 1989; Manci et al, 2003). To our knowledge,
there are no published data on the outcome of children with
SCD admitted to paediatric intensive care (PICU).
Population based data on the epidemiology of all children
admitted to PICU in the UK are reported to the Paediatric
Intensive Care Audit Network (PICANet) (Universities of
Leeds and Leicester 2008), established in 2002. However, there
is little published experience about children with SCD
admitted to PICU. There have been several studies reporting
outcomes for children with other conditions admitted to
PICU, with mortality rates of 44% and 38% for children with
bone marrow transplants (Jacobe et al, 2003) and HIV
(Cooper et al, 2004), respectively. We audited the admission
of children with SCD admitted to PICU at King’s College
Hospital (KCH) over 9 years, to define the reasons for
admission and outcome for this group, and to make compar-
isons with all children admitted to PICU.
Methods
We retrospectively audited all children with SCD admitted to
our PICU between 1st January 2000 and 31st December 2008.
KCH looks after about 400 children with SCD. We included all
patients admitted to PICU with SCD from birth to 16 years.
Information collected included presentation, treatment and
outcome; outcome data included reason for and length of
admission, the need for respiratory and inotropic support, use
of blood transfusion and antibiotics, time to hospital discharge
and mortality. Data were collected from PICU admission
books, patient case notes and electronic records.
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Summary
We retrospectively audited children with sickle cell disease (SCD) admitted to
paediatric intensive care (PICU) at King’s College Hospital between January
2000 and December 2008. Forty-six children with SCD were admitted, on 49
separate occasions. Ages ranged from 4 months to 15 years (median
7Æ6 years). Three children died in PICU, however two presented to hospital
in cardiorespiratory arrest; overall mortality was 6%. The most common
reason for admission was acute chest syndrome (43%). 88% of admissions
required blood transfusion, of which 74% had exchange blood transfusions.
The mortality among children with SCD admitted to PICU is low.
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Results
Patient demographics
Forty-six children with SCD (3 HbSC, 46 HbSS) were admitted
to PICU 49 times, accounting for 2% PICU admissions over
this 9-year period (Table I). Approximately 1000 children with
SCD live in the area served by KCH PICU, giving an admission
rate of approximately 0Æ5/100 patient years.
Reasons for admission
The most frequent reasons for admission to PICU were ACS
(43%, n = 21) and stroke (24%, n = 12), including three
subarachnoid haemorrhages (SAH) (Table II). Four (8%)
elective postoperative admission were planned due to a history
of complications. Acute surgical admissions comprised two
patients with acute hydrocephalus (one immediately post-stent
and coil embolization for cerebral aneurysm; one with a brain
tumour) and one patient with slipped upper femoral epiphysis
for central venous access and urgent exchange transfusion pre-
operatively. One patient was admitted with upper airway
obstruction due to massively enlarged tonsils. The patients
with other neurological problems include two with isolated
seizures, one with pneumococcal meningitis, and one with
cerebrovascular disease for urgent exchange transfusion. Two
patients with acute sepsis presented to hospital in cardiac
arrest and rapidly developed multi-organ failure.
Length of admission pre admission to PICU
Twenty-eight percent of patients (n = 13) were admitted
directly from the Emergency department to PICU. The
majority of patients were admitted to normal hospital wards
for at least 24 h (with 22% being admitted for more than 4 d)
before requiring admission to PICU. The majority of patients
with cerebrovascular accident (CVA) presented with acute
neurological symptoms and were transferred directly to PICU
on day 0, whereas typically patients with ACS were in hospital
for at least 24 h before being transferred to PICU.
Respiratory support
Thirty-five percent of patients (n = 17) required respiratory
support, one following CVA, two with multiorgan failure and
14 with ACS. The median length of respiratory support
(including non-invasive ventilation) was 2 d (range 1–18 d).
High frequency oscillatory ventilation (HFOV) was used in
seven admissions (14%). Five of these admissions were for ACS
and two had multi-organ failure secondary to sepsis. Five
(10%) were treated with inhaled nitric oxide (iNO); all had
ACS and survived to at least 6 months follow-up (Table II).
Inotropic support
Sixteen percent of patients (n = 8) required inotropic support:
three ACS, two multiorgan failure, one cerebral aneurysm, one
pneumococcal meningitis, one transient aplasia. Three of these
died (both multiorgan failure patients and the child with the
cerebral aneurysm). The five remaining patients survived to at
least 6 months follow-up.
Blood transfusion
Eighty-eight percent of patients (n = 43) required blood
transfusion on PICU, of which 74% (n = 32) had exchange
transfusions. Exchange blood transfusion was most commonly
performed for ACS (35%, n = 17), which accounted for 80%
of transfusions in those patients with ACS; the remaining
patients with ACS all had simple transfusion. Ten out of the 12
patients with CVA had exchange transfusion, and the other
two were already on a transfusion programme, with satisfac-
tory parameters at the time of admission.
Table I. Demographics of patients admitted to the intensive care unit
(n = 46).
Genotype HbSS: 43, HbSC: 3
Median age, years (range) 7Æ6 (0Æ4–15Æ7)
Hydroxycarbamide 2 (4%)
History of previous ACS 10 (22%)
Prescribed penicillin prophylaxis 46 (100%)
History of previous CVA 5 (11%)
Receiving regular blood transfusions 1 (2%)
Previous admission to PICU 5 (11%)
Transferred from outside hospital 13 (28%)
ACS, acute chest syndrome; CVA, cerebrovascular accident; PICU,
paediatric intensive care unit.
Table II. Reason for admission to paediatric intensive care, need for
ventilatory support, and outcome.
Reason for
admission
No. (%)
of total
admissions
(n = 49)
Ventilatory
support
(% of
Admission
Group)
Survived to
PICU discharge
(% of
Admission
Group)
ACS 21 (43) 6 (29) 21 (100)
CVA 12 (24) 2 (17) 11 (92)
Overwhelming sepsis 2 (4) 2 (100) 0 (0)
Other neurological 4 (8) 2 (50) 3 (75)
Elective post operative 4 (8) 1 (25) 4 (100)
Acute surgical 3 (6) 2 (67) 2 (100)
Upper airways
obstruction
1 (2) 1 (100) 1 (100)
Pain control 1 (2) 0 (0) 1 (100)
Aplasia unknown
cause
1 (2) 1 (100) 1 (100)
Total 49 (100) 17 (35) 46 (94)
PICU, paediatric intensive care unit; ACS, acute chest syndrome; CVA,
cerebrovascular accident.
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Antibiotics and lines
Eighty-two percent of patients (n = 40) were prescribed
antibiotics; all had an intravenous cephalosporins. 61%,
(n = 30) also had a macrolide. All admissions had peripheral
venous access. 30% (n = 15) had central venous catheters and
71% (n = 35) had arterial lines inserted.
Length of stay, treatment related morbidity and discharge
outcome
The median length of stay was 1 d (range 1–18 d). There was
one central line-associated thromboembolism, one delayed
transfusion reaction and one death was due to complications
post neurosurgical procedure. Three patients (6%) died on
PICU, although two of these had been transferred straight
from the Accident and Emergency department, having pre-
sented in cardiorespiratory arrest. Median time to discharge
from hospital after discharge from PICU was 4 d (range 0–
95 d). There were no further deaths before discharge from
hospital; one death occurred 4 months post-discharge due to
complication of a brain tumour, unrelated to SCD.
Comparison with PICANet data
Comparison of our data with that from all PICU admissions in
the UK (2005–2007) showed that children with SCD were
more significantly less likely to require ventilatory or inotropic
support, and had a similar mortality rate (Table III).
Discussion
This is the first study to characterize the use of PICU by
children with SCD. ACS and CVA were the commonest
reasons for admission. Three patients died during their
admission to PICU. One death was post-stent and coil
embolization for cerebral aneurysm causing a SAH, a proce-
dure that has a recognised mortality rate (Kurre & Berkefeld,
2008). The other two deaths were a result of multi-organ
failure secondary to presumed sepsis. Both of these children
were less than 2Æ5 years old, presented directly to the emer-
gency unit in cardiorespiratory arrest, and died within 24 h of
admission. An earlier study, looking at out-of-hospital paedi-
atric cardiac arrest found that survival to hospital discharge in
children requiring cardiopulmonary resuscitation in the
emergency department was low, at 15% (Schindler et al, 1996).
ACS was the most common reason for admission. There
were no deaths in this group. The outcome for ventilated
patients with ACS was very good, even those requiring
maximal support with HFOV and iNO. Our study confirms
previous reports that ACS is the leading cause of admission to
PICU in SCD (Platt et al, 1994). CVA was the second
commonest reason for admission to PICU. All CVA patients
received blood transfusion, with 83% having exchange trans-
fusions (Vichinsky et al, 2000); those not exchanged were
already on a transfusion programme with low HbS levels. In
young children, exchange transfusion is particularly difficult
and is often facilitated by the use of an arterial line for blood
removal, which necessitates admission to PICU. PICUs are also
useful in the care of children with acute neurological
symptoms in that close observation and neuroprotection are
easier than on a general ward.
One child presented with severe hypovolaemic shock
secondary to acute anaemia, with a haemoglobin of 17 g/l;
the reticulocyte count was low initially but repeated Parvovirus
B19 serology and nucleic acid testing were negative. The
patient required full PICU support but made a good recovery.
Only three children were admitted with septicaemia, and in
only one case was pneumococcus isolated. Other studies in the
United Kingdom have also observed lower than expected rates
of pneumococcal sepsis in patients with SCD (Telfer et al,
2007), suggesting the benefit of prophylactic antibiotics and
vaccination.
Fifteen (33%) of the patients admitted to PICU had a
history of either ACS or CVA. Thirty-eight percent of patients
admitted to PICU with ACS had a previous history of ACS and
63% of those previously required admission to PICU. Three
patients with CVA had previously had CVA; two of these
patients were not on a regular transfusion programme as
secondary stroke prevention; following prolonged discussions
and counselling, one family had decided to stop regular
transfusions and the other had started hydroxycarbamide. This
gives further support to the use of transfusion to prevent
recurrent stroke and demonstrates that discontinuing transfu-
sion increases the risk of further strokes (Pegelow et al, 1995;
Ohene-Frempong et al, 1998).
Mortality in the SCD patients was similar to that for all
patients admitted to PICU (Table III), although children with
SCD were significantly less likely to need ventilatory or
inotropic support. The most common reasons for admission in
the PICANet data were: ventricular septal defect 8%, respira-
tory failure 6Æ5%, status epilepticus 5Æ5%, sepsis 4Æ8%,
Table III. Comparison of our experience and with PICANet data.
P-values calculated using Chi-squared test with Yates’ correction.
PICANet
2005–2007
n = 43841
SCD cohort
KCH
2000–2008
n = 49 P
% needing non-invasive
ventilation
13% 2% 0Æ039
% needing invasive
ventilation
66% 33% <0Æ0001
% needing inotropes 31% 16% 0Æ039
Mortality 5% 6% 0Æ97
Length of stay (d) 32% stayed
1–3 d
Median 1;
mean 2
PICANet, paediatric intensive care audit network; SCD, sickle cell
disease; KCH, King’s College Hospital NHS Foundation trust.
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pneumonia 4Æ1%, asthma 2% and intracranial tumour 2%.
Although the reasons for admission were different, length of
stay was similar. Limited inferences can be made from our
audit because it is a single-centre, retrospective study involving
relatively small numbers, although outcome appears to be
equivalent to unselected PICU admissions.
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